These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 19572275)

  • 1. Influence of age and gender on dose and effectiveness of botulinum toxin for laryngeal dystonia.
    Vasconcelos S; Birkent H; Sardesai MG; Merati AL; Hillel AD
    Laryngoscope; 2009 Oct; 119(10):2004-7. PubMed ID: 19572275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia.
    Birkent H; Maronian N; Waugh P; Merati AL; Perkel D; Hillel AD
    Otolaryngol Head Neck Surg; 2009 Jan; 140(1):43-7. PubMed ID: 19130960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction.
    Gupta M; Patel T; Xavier K; Maruffo F; Lehman D; Walsh R; Landman J
    J Urol; 2010 Feb; 183(2):598-602. PubMed ID: 20018320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
    Casserly P; Timon C
    J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
    Suputtitada A; Phanthumchinda K; Locharernkul C; Suwanwela NC
    J Med Assoc Thai; 2004 Oct; 87(10):1205-11. PubMed ID: 15560699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of botulinum toxin type A for chronic cough: a neuropathic model.
    Chu MW; Lieser JD; Sinacori JT
    Arch Otolaryngol Head Neck Surg; 2010 May; 136(5):447-52. PubMed ID: 20479373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
    Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
    J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergence spasm treated with botulinum toxin.
    Kaczmarek BB; Dawson E; Lee JP
    Strabismus; 2009; 17(1):49-51. PubMed ID: 19301195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
    Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection.
    Warrick P; Dromey C; Irish JC; Durkin L; Pakiam A; Lang A
    Laryngoscope; 2000 Aug; 110(8):1366-74. PubMed ID: 10942143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
    Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
    Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
    Sankhla C; Jankovic J; Duane D
    Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia.
    Chang CY; Chabot P; Thomas JP
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):894-9. PubMed ID: 17547976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A.
    Grillone GA; Blitzer A; Brin MF; Annino DJ; Saint-Hilaire MH
    Laryngoscope; 1994 Jan; 104(1 Pt 1):30-2. PubMed ID: 8295454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensor truncal dystonia: successful treatment with botulinum toxin injections.
    Comella CL; Shannon KM; Jaglin J
    Mov Disord; 1998 May; 13(3):552-5. PubMed ID: 9613753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term botulinum toxin efficacy, safety, and immunogenicity.
    Mejia NI; Vuong KD; Jankovic J
    Mov Disord; 2005 May; 20(5):592-7. PubMed ID: 15645481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II.
    Rubin AD; Wodchis WP; Spak C; Kileny PR; Hogikyan ND
    Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):415-20. PubMed ID: 15096423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
    Loven JO; Brøndbo K; Ganes T
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.